. . . . . . . . . . . . "Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis"@en . . . "55"^^ . . "NCT00355134" . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . . . . . . . "klinisch onderzoek"@nl . "18"^^ . . . . . . . . . "Efficacy and Safety of Fingolimod"@nl . . . . . . . . . . . "1083"^^ . . . . . . "FREEDOMS II"@en . . . "Efficacy and Safety of Fingolimod"@nl . . "Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis"@en . . "clinical trial"@en . . . "Efficacy and Safety of Fingolimod"@nl . "ensayu cl\u00EDnicu"@ast . . "Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis"@en . . "24-month Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720) Administered Orally Once Daily Versus Placebo in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase"@en . . . . . . . . . "2006-06-01T00:00:00Z"^^ . "2011-06-01T00:00:00Z"^^ . . . . . . .